For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
![Harrisburg is taking a wrong approach to drug pricing | PennLive letters](https://cei.org/wp-content/uploads/2024/06/GettyImages-1343695751-578x324-c-default.jpg)
Penn Live
Harrisburg is taking a wrong approach to drug pricing | PennLive letters
CEI’s Joel Zinberg was cited in a Penn Live article on Pharmacy Benefit Managers: Joel Zinberg from the Competitive Enterprise Institute (CEI) explains, “PBMs enhance…
![Biden’s got a plan to protect science from Trump](https://cei.org/wp-content/uploads/2024/05/GettyImages-611863118-578x324-c-default.jpg)
Politico
Biden’s got a plan to protect science from Trump
CEI’s Joel Zinberg was cited in Politico on the obstacles Trump faces with the NIH: Trump should have no illusions about what he’s up against,…
![New FDA lab tests rule could bankrupt small labs](https://cei.org/wp-content/uploads/2023/07/GettyImages-1293772969-578x324-c-default.jpg)
Blog
New FDA lab tests rule could bankrupt small labs
Yesterday the Food and Drug Administration (FDA) announced that on May 6 it will promulgate a rule under its authority to regulate medical devices.
Search Posts
News Release
Listen to CEI’s Radio and TV ads on Drug Lag–the delayed availability of new therapies due to FDA regulation
CEI’s radio ad on FDA’s drug approval system, Ocean Storm, is available at: http://cei.org/sites/default/files/CEI_Radio_Storm.mp3 CEI’s television ad is available at:…
Study
Breaking The FDA’s Drug Approval Monopoly:
Executive Summary The Food and Drug Administration’s monopoly over approving new medical therapies is premised on the idea that information markets fail. In…
Op-Eds
Nailed by FDA
I started 1996 with two new experiences. I had a close-up photograph taken of my big toe, and I had my first personal run-in with…
Products
Rachel Was Wrong
Rachel Carson's Silent Spring ushered in an era of national concern over the potential effects of synthetic chemicals. Published in 1962, Carson's book suggested that…
Study
Rachel’s Folly: The End of Chlorine
Full Document Available in PDF The environmentalists are right about one thing: Dirty…
News Release
Press Conference: Public in Dark about Alcohol and Heart Disease
WASHINGTON, DC November 6, 1995—CEI today releases a poll showing that over half the American public does not know about the cardiovascular benefits of…